Az oktató a doktori iskola doktoranduszai számára oktat tantárgyat, és/vagy a doktori iskola megszavazta, hogy doktoranduszok számára kutatási témát írjon ki.
The aim of research group is to develop new compounds to fight retinopathies. Our vision is to replace intravitreal injections by new drugs that can be taken per os to push back neovascularization
research field in which current research is conducted
monographs/books in which chapters/sections were contributed:
number of independent citations to scientific publications and creative works:
The number of citations displayed after clicking on the link may differ from the displayed number because the former displays the current state of MTMT2 and the latter was the case when importing science metrics.
further relevant information regarding accreditation (in Hungarian)
The topic under the title „Local inhibition of retinal VEGF signaling by targeting small molecule tyrosine-kinase inhibitors to the retina to fight retinopathies with neovascularization” and lead by Dr. Krisztián Kovács has been accredited under by the EDT under the decree 58/2022 (10.24). The corresponding PhD work can be started in the Institute of Translational Medicine of the Semmelweis University
2024. IV. 17. ODT ülés Az ODT következő ülésére 2024. június 14-én, pénteken 10.00 órakor kerül sor a Semmelweis Egyetem Szenátusi termében (Bp. Üllői út 26. I. emelet).
Login
med.semmelweis-univ.hu
